TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.57B
AUM Growth
-$21.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
198
New
Increased
Reduced
Closed

Top Buys

1
+$38.2M
2
+$20.1M
3
+$13.7M
4
NKTR icon
Nektar Therapeutics
NKTR
+$13.2M
5
BMY icon
Bristol-Myers Squibb
BMY
+$11.2M

Top Sells

1
+$34.4M
2
+$27.5M
3
+$18.3M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$17.9M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$16.9M

Sector Composition

1 Healthcare 93.47%
2 Real Estate 2.71%
3 Financials 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$156M 6.05%
2,063,699
-456,582
2
$121M 4.69%
1,352,842
-161,062
3
$119M 4.65%
700,588
-161,586
4
$114M 4.45%
893,082
+156,950
5
$104M 4.03%
378,703
-66,904
6
$100M 3.89%
614,084
-29,678
7
$75.4M 2.93%
352,317
+46,431
8
$72.8M 2.83%
2,162,748
+1,135,006
9
$71.1M 2.77%
1,726,967
+123,855
10
$69.9M 2.72%
1,345,655
-40,005
11
$69.7M 2.71%
303,149
+9,356
12
$55.6M 2.16%
498,975
-160,643
13
$53.8M 2.09%
645,442
-47,833
14
$48.1M 1.87%
139,560
-30,956
15
$47.9M 1.86%
798,619
16
$42.7M 1.66%
450,738
+104,425
17
$41.9M 1.63%
522,211
+16,185
18
$41.9M 1.63%
248,836
+40,656
19
$37.7M 1.47%
486,865
+103,766
20
$33.3M 1.29%
525,722
+176,601
21
$31.9M 1.24%
118,733
-19,823
22
$30.5M 1.19%
147,855
+9,887
23
$29.3M 1.14%
153,076
+20,724
24
$28.4M 1.1%
391,738
-34,442
25
$28M 1.09%
378,516
+44,116
1
2 3 4 5